# Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

Study · id `cardio:ct-nct03706833` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03706833](<https://clinicaltrials.gov/study/NCT03706833>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03706833

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1247 participants.

## Technical summary

Registry record NCT03706833. Randomized; no masking; primary purpose treatment. Start 2018-11-30 (actual); primary completion 2026-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1247 participants (planned count; ClinicalTrials.gov record NCT03706833, source copy `cardio:ctgov-nct03706833-2026-07-08`, retrieved 2026-10-26)
- Started: 2018-11-30 (actual) (ClinicalTrials.gov record NCT03706833, source copy `cardio:ctgov-nct03706833-2026-07-08`, retrieved 2026-10-26)
- Primary completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT03706833, source copy `cardio:ctgov-nct03706833-2026-07-08`, retrieved 2026-10-26)
- Completion: 2031-06-30 (anticipated) (ClinicalTrials.gov record NCT03706833, source copy `cardio:ctgov-nct03706833-2026-07-08`, retrieved 2026-10-26)
- Countries: United States; Canada; Germany; Switzerland (ClinicalTrials.gov record NCT03706833, source copy `cardio:ctgov-nct03706833-2026-07-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03706833-2026-07-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
- Acronym: CLASP IID/IIF
- Condition: Degenerative Mitral Valve Disease
- Condition: Mitral Regurgitation
- Condition: Mitral Insufficiency
- Condition: Functional Mitral Regurgitation
- Intervention (Device): Edwards PASCAL System
- Intervention (Device): Abbott Mitraclip System
- Lead sponsor: Edwards Lifesciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Edwards Lifesciences (`cardio:edwards-lifesciences`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Residual Mitral Regurgitation and Gradient After M‑TEER: 1‑Year Outcomes From the CLASP IID Trial (`cardio:pubmed-42233921`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b0e5ed8afc101b2187599f51e308f9a055319554b53fb43d27f5375c6d551011
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
